Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
SPRÁVA Z VÝROČNEJ KONFERENCIE AMERICKEJ ONKOLOGICKEJ SPOLOČNOSTI 2017 Genitourinárne malignity
29 septembra, 2020 8:30 pmV dňoch 2. – 6. júna 2017 sa v americkom Chicagu uskutočnila výročná konferencia Americkej onkologickej spoločnosti (ASCO). Tak ako každý rok,...
Overall survival results of ICON6: A trial of chemotherapy and cediranib in relapsed ovarian cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5506 Citation: J Clin Oncol 35, 2017...
Circulating tumor DNA analysis using targeted sequencing of 508 clinically actionable genes in patients with high grade serous ovarian cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5582 Citation: J Clin Oncol 35, 2017...
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5505 Citation: J Clin Oncol 35, 2017...
Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5502 Citation: J Clin Oncol 35, 2017...
Treatment and outcomes of small cell neuroendocrine carcinoma of the cervix (SCCC)
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5531 Citation: J Clin Oncol 35, 2017...
Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5514 Citation: J Clin Oncol 35, 2017...
An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5504 Citation: J Clin Oncol 35, 2017...
LION: Lymphadenectomy in ovarian neoplasms – A prospective randomized AGO study group led gynecologic cancer intergroup trial
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Oral Abstract Session Abstract number: 5500 Citation: J Clin Oncol 35,...
Strategic Combinations in Ovarian Cancer
29 septembra, 2020 8:30 pmJune 3, 2017 The introduction of PARP inhibitors revolutionized the treatment of ovarian cancer, providing much-needed therapeutic options. However,...